Filed: 8/14/2026ACC: 0002077247-26-000004
📋 What this filing means
TRAILS EDGE CAPITAL PARTNERS, LP filed this quarterly 13F‑HR report disclosing 35 equity positions with a total reported market value of $629.91M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
35
Positions
$629.91M
Total AUM (reported)
48.72M
Total Shares
Allocation by class
COM$306.52M48.7%
COM NEW$106.06M16.8%
COM SHS$56.76M9.0%
ADS$43.80M7.0%
ORD SHS$30.46M4.8%
COM PAR $.01$24.56M3.9%
COMMON STOCK$21.69M3.4%
Portfolio Concentration
Top 3$121.35M19.3%
4–10$195.61M31.1%
11–25$248.58M39.5%
Rest$64.37M10.2%
Top 3 weight
19.3%
Top 10 weight
50.3%
Voting Authority Distribution
Total shares with voting rights: 48.72M
Sole
Full voting authority
48.72M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole35
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings35
Rows:
LB PHARMACEUTICALS INC
SOLEShares1.52M
TypeSH
Market value$49.43M
7.85%
Sole
1.52M
Shared
0.00
None
0.00
NURIX THERAPEUTICS INC
SOLEShares1.57M
TypeSH
Market value$38.17M
6.06%
Sole
1.57M
Shared
0.00
None
0.00
IMMUNOCORE HLDGS PLC
SOLEShares1.06M
TypeSH
Market value$33.76M
5.36%
Sole
1.06M
Shared
0.00
None
0.00
FIRST TRACKS BIOTHERAPEUTICS
SOLEShares1.51M
TypeSH
Market value$30.46M
4.84%
Sole
1.51M
Shared
0.00
None
0.00
4D MOLECULAR THERAPEUTICS IN
SOLEShares2.23M
TypeSH
Market value$29.63M
4.70%
Sole
2.23M
Shared
0.00
None
0.00
BIOMARIN PHARMACEUTICAL INC
SOLEShares512K
TypeSH
Market value$29.30M
4.65%
Sole
512K
Shared
0.00
None
0.00
DESIGN THERAPEUTICS INC
SOLEShares2M
TypeSH
Market value$28.96M
4.60%
Sole
2M
Shared
0.00
None
0.00
XENON PHARMACEUTICALS INC
SOLEShares440K
TypeSH
Market value$26.56M
4.22%
Sole
440K
Shared
0.00
None
0.00
MIRUM PHARMACEUTICALS INC
SOLEShares223.31K
TypeSH
Market value$26.14M
4.15%
Sole
223.31K
Shared
0.00
None
0.00
INSMED INC
SOLEShares230.33K
TypeSH
Market value$24.56M
3.90%
Sole
230.33K
Shared
0.00
None
0.00
CYTOKINETICS INC
SOLEShares288.09K
TypeSH
Market value$24.54M
3.90%
Sole
288.09K
Shared
0.00
None
0.00
SYNDAX PHARMACEUTICALS INC
SOLEShares1.11M
TypeSH
Market value$24.26M
3.85%
Sole
1.11M
Shared
0.00
None
0.00
NEUROGENE INC
SOLEShares714.88K
TypeSH
Market value$22.48M
3.57%
Sole
714.88K
Shared
0.00
None
0.00
KAILERA THERAPEUTICS INC
SOLEShares984.79K
TypeSH
Market value$21.69M
3.44%
Sole
984.79K
Shared
0.00
None
0.00
REVOLUTION MEDICINES INC
SOLEShares115.75K
TypeSH
Market value$21.68M
3.44%
Sole
115.75K
Shared
0.00
None
0.00
INHIBIKASE THERAPEUTICS INC
SOLEShares9.05M
TypeSH
Market value$18.37M
2.92%
Sole
9.05M
Shared
0.00
None
0.00
INCYTE CORP
SOLEShares155K
TypeSH
Market value$17.57M
2.79%
Sole
155K
Shared
0.00
None
0.00
AVALO THERAPEUTICS INC
SOLEShares891.88K
TypeSH
Market value$16.48M
2.62%
Sole
891.88K
Shared
0.00
None
0.00
MOONLAKE IMMUNOTHERAPEUTICS
SOLEShares750K
TypeSH
Market value$14.60M
2.32%
Sole
750K
Shared
0.00
None
0.00
FAETH THERAPEUTICS INC
SOLEShares515.34K
TypeSH
Market value$12.88M
2.05%
Sole
515.34K
Shared
0.00
None
0.00
X4 PHARMACEUTICALS INC
SOLEShares2.57M
TypeSH
Market value$12.01M
1.91%
Sole
2.57M
Shared
0.00
None
0.00
OPUS GENETICS INC
SOLEShares2.74M
TypeSH
Market value$11.28M
1.79%
Sole
2.74M
Shared
0.00
None
0.00
SOL-GEL TECHNOLOGIES LTD
SOLEShares139.44K
TypeSH
Market value$10.34M
1.64%
Sole
139.44K
Shared
0.00
None
0.00
AURA BIOSCIENCES INC
SOLEShares1.44M
TypeSH
Market value$10.25M
1.63%
Sole
1.44M
Shared
0.00
None
0.00
CENTURY THERAPEUTICS INC
SOLEShares4.13M
TypeSH
Market value$10.13M
1.61%
Sole
4.13M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
LB PHARMACEUTICALS INCSOLE | COM SHS | 1.52M | SH | $49.43M 7.85% | 1.52M | 0.00 | 0.00 |
NURIX THERAPEUTICS INCSOLE | COM | 1.57M | SH | $38.17M 6.06% | 1.57M | 0.00 | 0.00 |
IMMUNOCORE HLDGS PLCSOLE | ADS | 1.06M | SH | $33.76M 5.36% | 1.06M | 0.00 | 0.00 |
FIRST TRACKS BIOTHERAPEUTICSSOLE | ORD SHS | 1.51M | SH | $30.46M 4.84% | 1.51M | 0.00 | 0.00 |
4D MOLECULAR THERAPEUTICS INSOLE | COM | 2.23M | SH | $29.63M 4.70% | 2.23M | 0.00 | 0.00 |
BIOMARIN PHARMACEUTICAL INCSOLE | COM | 512K | SH | $29.30M 4.65% | 512K | 0.00 | 0.00 |
DESIGN THERAPEUTICS INCSOLE | COM | 2M | SH | $28.96M 4.60% | 2M | 0.00 | 0.00 |
XENON PHARMACEUTICALS INCSOLE | COM | 440K | SH | $26.56M 4.22% | 440K | 0.00 | 0.00 |
MIRUM PHARMACEUTICALS INCSOLE | COM | 223.31K | SH | $26.14M 4.15% | 223.31K | 0.00 | 0.00 |
INSMED INCSOLE | COM PAR $.01 | 230.33K | SH | $24.56M 3.90% | 230.33K | 0.00 | 0.00 |
CYTOKINETICS INCSOLE | COM NEW | 288.09K | SH | $24.54M 3.90% | 288.09K | 0.00 | 0.00 |
SYNDAX PHARMACEUTICALS INCSOLE | COM | 1.11M | SH | $24.26M 3.85% | 1.11M | 0.00 | 0.00 |
NEUROGENE INCSOLE | COM | 714.88K | SH | $22.48M 3.57% | 714.88K | 0.00 | 0.00 |
KAILERA THERAPEUTICS INCSOLE | COMMON STOCK | 984.79K | SH | $21.69M 3.44% | 984.79K | 0.00 | 0.00 |
REVOLUTION MEDICINES INCSOLE | COM | 115.75K | SH | $21.68M 3.44% | 115.75K | 0.00 | 0.00 |
INHIBIKASE THERAPEUTICS INCSOLE | COM NEW | 9.05M | SH | $18.37M 2.92% | 9.05M | 0.00 | 0.00 |
INCYTE CORPSOLE | COM | 155K | SH | $17.57M 2.79% | 155K | 0.00 | 0.00 |
AVALO THERAPEUTICS INCSOLE | COM NEW | 891.88K | SH | $16.48M 2.62% | 891.88K | 0.00 | 0.00 |
MOONLAKE IMMUNOTHERAPEUTICSSOLE | CLASS A ORD | 750K | SH | $14.60M 2.32% | 750K | 0.00 | 0.00 |
FAETH THERAPEUTICS INCSOLE | COM NEW | 515.34K | SH | $12.88M 2.05% | 515.34K | 0.00 | 0.00 |
X4 PHARMACEUTICALS INCSOLE | COM NEW | 2.57M | SH | $12.01M 1.91% | 2.57M | 0.00 | 0.00 |
OPUS GENETICS INCSOLE | COM | 2.74M | SH | $11.28M 1.79% | 2.74M | 0.00 | 0.00 |
SOL-GEL TECHNOLOGIES LTDSOLE | SHS NEW | 139.44K | SH | $10.34M 1.64% | 139.44K | 0.00 | 0.00 |
AURA BIOSCIENCES INCSOLE | COM | 1.44M | SH | $10.25M 1.63% | 1.44M | 0.00 | 0.00 |
CENTURY THERAPEUTICS INCSOLE | COM | 4.13M | SH | $10.13M 1.61% | 4.13M | 0.00 | 0.00 |
Page 1 of 2